Physicians' Academy for Cardiovascular Education

Phase 1 Study of CAT-2054, a Novel Oral Modulator of Sterol Regulatory Element Binding Protein

Slides (presentation) - June 18, 2015

Presentation prepared and held by Dr Joanne Donovan (Cambridge MA, USA) in Clinical Breakthroughs: A plethora of new therapeutic targets, May 2015, ISA2015 (Amsterdam, The Netherlands).

Phase 1 Study of CAT-2054, a Novel.pdf (0,8MB)Phase 1 Study of CAT-2054.pdf (0,8MB)

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.